Stockreport

Heron's Way Ahead: Is There Further Upside? [Seeking Alpha]

Heron Therapeutics, Inc.  (HRTX) 
Last heron therapeutics, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: herontherapeutics.gcs-web.com/investor-home
PDF Summary Heron Therapeutics ( HRTX ) is an emerging biopharma with two drugs - SUSTOL and CINVANTI - both approved for preventing CINV or Chemotherapy-Induced Nausea [Read more]